Monday, September 16, 2013

bird flu in economic prespective

A Different Approach to Develop avian influenza do drugss Introduction In 2003, a new biologic threat arises from the east, it is called Avian Flu or in laymans bound bird flu. One strand that has been place by scientists to be highly lethal is H5N1 computer virus. Although the spread of virus has been r ar, in that respect are sufficient findings showing that the virus is evolving into more efficient and tranquil killer (CDC). It is only a matter of time in the first place the virus becomes easily transferable from human to human via air. In the midst of all of this, the pharmaceuticals companies are jostling, lobbying, and fighting over reassure monopolies rights to secure future lollys. One then must ask, what is load of raking considerable profits, when everyone that you know is dead. As a result, developed nations who contrive the with child(p) and technical know-how are lagging behind monitoring, treating, and creating vaccinum for this evolving motio nless killer. It does not take a rocket scientist to foreshadow monopoly. To move on private sector to develop new drugs, the politics grants patent monopolies. With it, they can sell drugs at insane prices, curiously when there is very limited argument or substitution. For example, a drug that usually cost in the market $.01 per pill ends up costing $ atomic number 6 or even more.
bestessaycheap.com is a professional essay writing service at which you can buy essays on any topics and disciplines! All custom essays are written by professional writers!
This is the dilemma veneering the pharmaceuticals world today. The patent drug Tamiflu, a drug that is considered well-nigh effective in treating avian flu is held by Roche, a Swiss pharmaceutical range (MacKellar). A monopolizer company such a s Roche would prefer zero competition if pos! sible. And, if Roche is forced to license production of Tamiflu, they willing have little bonus to research new drugs. The pharmaceutical industry argues that licensing will belittle their future profit. The industrys argument is indeed valid, yet to what extent. Suppose Roche by licensing Tamiflu lose $70 profit from $100 per item, technically theyre still making a profit. And the faithfulness of business states that as...If you want to get a dear essay, order it on our website: BestEssayCheap.com

If you want to get a full essay, visit our page: cheap essay

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.